Translational Bytes
To read the full post, please click on the title.

Last year, the drug-development community, regulators, medical practitioners, and the public were shocked by the unanticipated serious adverse events in healthy subjects in a study of a small molecule fatty acid amide hydroxylase inhibitor BIA-102474. This tragic development precipitated...[read more
A Potential New Clinical Biomarker for Multiple Sclerosis – Quantification of Galactosylceramide
Advancements in the discovery and development of new therapeutics are often limited by the lack of robust biomarkers to assess drug activity.  In a recent paper in Clinical and Translational Science...[read more]
Awarded the “Design of the Year” by the London Design Museum in 2015, microphysiological systems or “organs-on-chips” could fundamentally change drug toxicity testing. Despite decades of research using animal and cell models, predicting drug-induced toxicity in humans...[read more
Precision medicine is based on a simple precept that deep information about an individual patient can be used to guide his or her health care. In the not-too-distant future, clinicians may have point-of-care access to an individual’s entire genome, dense data captured from wearable devices, and...[read more]
With the advent of the 2017 ASCPT annual meeting, the editorial team and staff thank the membership, authors, and readers ofCTS for an outstanding year.  CTS concluded its first year of publication as an official journal of ASCPT with many accomplishments, and looks forward to...[read more]
528 N Washington St, Alexandria, VA 22314 |  Ph: 703.836.6981 |